CHEMERIN IS AN INDISPENSABLE PRE-TREATMENT PREDICTOR OF SOFOSBUVIR, PEGYLATED INTERFERON-ALPHA AND RIBAVIRIN OUTCOMES IN CHRONIC HEPATITIS C EGYPTIAN PATIENTS

MOLECULAR AND BIOCHEMICAL STUDIES ON HEPATITIS C PATIENTS RELAPSED AFTER SOFOSBUVIR TREATMENT

Assessing TGF β1 Gene Expression as a Prognostic Marker for Hepatocellular Carcinoma Development in HCV patients receiving Direct-Acting Antiviral (DAAs) Therapy

Biochemical and Molecular Alterations of Micro RNA 125b and Micro RNA 489-3p as diseases biomarkers in Hepatitis C Virus (HCV)

A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

MOLECULAR CHARACTERIZATION OF INTERLEUKIN IN CHRONIC HCV.

Can Fibrogenesis Markers Reflect Early Hepatic Histopathology in Chronic Hepatitis C?

Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C